Objectives. To recognize current opioid prescription patterns in otolaryngology and determine changes in rates of outpatient opioid prescribing over time.
T he opioid epidemic is a topic of increasing national concern. Since 1999, sale of opioid prescriptions and opioid-related deaths have both nearly quadrupled. 1 In 2015, . 16 ,000 deaths in the United States were attributable to prescription narcotics. 2, 3 Efforts to control the epidemic are underway. The National Institutes of Health has announced plans to work with private partners to develop new approaches for overdose reversal, prevention interventions, and novel nonaddictive compounds to battle the epidemic. 4 The White House established a Commission on Combating Drug Addiction and the Opioid Crisis. Nearly every state has implemented prescription drug-monitoring programs with varying success, such as California's CURES 2.0 database (Controlled Substance Utilization Review and Evaluation System), which tracks prescription and dispensing of controlled substances. [5] [6] [7] [8] But containing the crisis requires careful assessment of the prescription patterns of opioids, which until the 1980s were primarily prescribed for acute pain and cancer-related pain. 9 In surgical fields, unused postoperative narcotics were shown to be an important source of nonmedical usage and a potential etiology of dependence and morbidity. 10 Among patients with oral cavity cancer, chronic postoperative opioid use has been associated with decreased survival. 11 While limiting the amount of opioid prescribed in the postoperative setting is a common focus for prevention strategies, 12, 13 ambulatory opioid prescription is also an important target.
14 In this study, we aimed to evaluate outpatient opioid prescription patterns and trend changes in rates of opioid prescribing over time among ambulatory otolaryngology visits.
Methods
The data source for this study was the National Ambulatory Medical Care Survey (NAMCS) administered by the Centers for Disease Control and Prevention (CDC). Field data collection for the NAMCS is conducted primarily by site visits from US Bureau of the Census representatives with physicians and medical staff. A systematic random sampling of patient visits are selected for data collection. Single-page patient record forms, which are later de-identified, are used to collect data for each sampled visit. Prescription rate information is obtained from data collected through the patient record forms at the time of the sampled visit. Medication information is coded with a classification scheme developed at the National Center for Health Statistics. 15 This study was reviewed by our hospital's institutional review board and deemed exempt as it utilizes de-identified publicly available data. The NAMCS data sets for the calendar years 2006 to 2013 inclusive were combined. All cases of office visits coded as occurring with a physician specialty provider in otolaryngology were extracted.
For each visit, extracted demographic information included year of visit, diagnosis codes, age, sex, child status (defined as age \18.0 years), and up to 8 prescribed medications at the visit. The medications that are tabulated include new prescriptions and continued medications at the conclusion of the visit. Based on the clinical classification scheme contained within the NAMCS for medications, prescriptions for opioids as a drug class occurring or not occurring with each otolaryngology visit were assessed.
National estimates for the number of outpatient otolaryngology visits with and without an opioid prescription were determined. The relative prescription rates for opioids were compared between female and male patients, between child and adult patients, and according to race/ethnicity. Differential rates of opioid prescribing were determined according to individual calendar year and trended by grouping years biennially. Furthermore, associations were tabulated between the most common ambulatory diagnoses and those receiving opioids. Because of the recent ''black box'' Food and Drug Administration (FDA) warning regarding pediatric administration of codeine for pain control after tonsillectomy and adenoidectomy, we conducted a separate subanalysis among children with respect to whether codeine was the prescribed opioid agent.
The complex samples algorithm in SPSS 22.0 (IBM, Chicago, Illinois) was used to incorporate the clustered, stratified, and weighted sampling methodology in the NAMCS. Statistics were considered reliable if they met National Center for Healthcare Statistics criteria for reliability with a relative standard error \30%. Statistical significance was set at P = .05. Data are presented as mean 6 SE of the estimate where appropriate.
Results
There were 19.2 6 1.7 million ambulatory otolaryngology annual visits in the United States from 2006 to 2013 (raw n = 11,905), of which 728,000 6 96,000 (3.8% 6 0.4%) involved an opioid prescription ( Table 1) . No significant difference in narcotic prescription rate between sexes was noted (P = .567), and adults were more likely than children to receive a narcotic (P \ .001). When stratified by race categories, non-Hispanic white patients had the largest overall number of prescriptions, while non-Hispanic black patients had the highest opioid prescription rate, although this did not reach significance (P = .132). Notably, not all visits had data on race recorded; therefore, these results were based on approximately 552,000 6 83,000 visits of the 728,000 6 96,000 mentioned (75.8%).
With respect to calendar trend, the opioid prescription rate increased significantly from 2.3% 6 0.4% in 2006-2007 to 4.6% 6 0.7% in 2008-2011, followed by a small decrease in 2012-2013 (P \ .031) ( Figure 1 ). Postoperative care was the most common diagnosis associated with an opioid prescription; other diagnoses are shown in Table 2 .
Of the 728,000 6 96,000 visits involving an opioid prescription, the 5 most common prescribed medications were hydrocodone/acetaminophen, oxycodone/acetaminophen, propoxyphene, codeine/acetaminophen, and methadone. The most common brands are shown in Table 3 . Notably, propoxyphene was withdrawn from the market in 2010 due to concern for cardiac side effects, including QT interval prolongation.
We also examined pediatric prescription of codeine, given that the FDA issued a black box warning in 2013 with regard to the safety of the drug following tonsillectomy and/or adenoidectomy. From 2006 to 2013, of all children who received narcotic prescriptions at outpatient otolaryngology visits annually (82,430 6 13,906 patients), 22.2% 6 5.3% (18,280 6 5,300 patients) received prescriptions for codeine products.
Discussion
The magnitude of the opioid crisis is staggering: the annual economic burden of prescription opioid overdose, abuse, and dependence was estimated at $78.5 billion in 2013. 16 In the ambulatory setting, total expenses for outpatient opioids increased from $4.1 billion in 2002 to $9.0 billion in 2012. During the same time frame, the number of US civilians purchasing outpatient prescribed opioids increased from 27.2 million to 36.7 million. 17 Outpatient prescribing patterns are evidently an important target for addressing the burgeoning crisis. However, in otolaryngology, normative data are lacking. To our knowledge, this is the first quantitative study of outpatient opioid prescription in the otolaryngology literature. The value of the investigation lies in establishing prescribing pattern benchmarks for common otolaryngologic diagnoses and monitoring trends in otolaryngology as compared with national averages.
The data presented herein indicate that only a minority of outpatient otolaryngology visits result in prescription of opioids and that demographic differences in prescribing are not significant. Prescriptions are equally distributed between men and women ( Table 1 ). Sex differences in prescription opioid use have been minimally studied, and there are variable reports regarding a greater prevalence in 1 sex. 18, 19 According to data from the CDC in 2013, more men die from drug overdoses than women, although women have had a greater percentage increase in deaths in recent years. 20 Another study suggested that while prevalence may be equivalent, approaches to management of dependence are different: men may benefit more from behavioral monitoring, while women may benefit from support for physical and psychological effects of pain. 21 With respect to race, non-Hispanic black patients trended toward the highest opioid prescription rate in our analysis (Table 1) . However, in contrast, much of the data on racial differences in opioid prescription come from the emergency medicine literature, where disparities reflect that minorities are less likely to receive opioid prescriptions. 22, 23 An apparent paucity of literature exists on sex differences and racial disparities in opioid prescription outside the emergency setting and requires further study.
With regard to age, a higher proportion of adults receiving narcotic scripts as opposed to children seems consistent with our expectations for multiple reasons. Children are more often opioid naïve, with higher responsivity to nonopioid analgesics; they typically have fewer chronic pain complaints; and they are more vulnerable to accidental overdose than adults-especially young children in homes where mothers themselves have opioid prescriptions. 24 Furthermore, the rate of opioid prescription among children (inclusive of the postoperative and ambulatory setting) has been relatively stable at around 2.6% to 2.9% of all children over the past 20 years despite rising adult prescription rates. 25 This is comparable to our observed rate of 1.9% for pediatric outpatient opioid prescriptions alone. With respect to codeine prescription in pediatric otolaryngology, our data revealed that of those children who received narcotics, .1 in every 5 received codeine products (22.2% 6 5.3%). While this value is relatively high, it is reassuring that the majority of data predate the FDA black box warning in 2013. Analysis of postwarning opioid prescription rates was unable to be performed, as the NAMCS did not yet contain these data at the time of data extraction. Goldman et al showed that posttonsillectomy pediatric codeine prescription rates at 1 center dropped to nearly zero following the warning 26 ; a follow-up to the present study may be warranted for corroboration on a national scale. A larger recent study of .350,000 patients undergoing posttonsillectomy and/or adenoidectomy showed a significant decrease in usage after the warning but also revealed that even as late as December 2015, 1 in 20 children (5%) undergoing these procedures were still prescribed codeine despite its known risks. 27 The results of the most common diagnoses resulting in an opioid prescription ( Table 2 ) were largely predictable. Postoperative care reflects the majority of prescriptions for uncontrolled pain following surgery and any painful complications. Adenotonsillitis is rarely painful enough to require opiates; therefore, we suspect that the group includes miscoded severe pharyngitis or peritonsillar abscess cases. Nasal obstruction also likely includes traumatic nasal fractures or septal deviations. Obstructive sleep apnea had a moderately high association with opioid prescription (4.1% 6 1.3%), presumably due to postoperative refills after procedures for it. As a high-risk population with increased perioperative morbidity, these patients require, per guidelines, 28 particular vigilance from the prescribing clinician with the goal of minimizing all systemic opioids in the postoperative setting.
Notably, there were unexpected diagnoses, such as aging face and hearing loss, included. We attribute these findings to preoperative diagnosis codes that were not changed postoperatively-for example, a patient who presents for ''aging face'' concerns, undergoes a rhytidectomy, and is prescribed a pain medication refill at the postoperative visit while retaining the same preoperative diagnosis code, as opposed to a ''postoperative pain'' code. Alternatively, these findings may be due to erroneous coding in the database; however, the NAMCS has rigorous methods for ensuring the accuracy of data collection and minimizing the chance for errors.
The most commonly prescribed opioids, hydrocodone and oxycodone, were consistent with CDC reports as well as previous studies ( Table 3) . 29 Notably, since 2013, fentanyl (illicit and prescribed) has become a significant contributor to opioid-related mortality and will be important to monitor as the epidemic persists.
In addition to ambulatory opioid prescriptions, one of the most concerning aspects of the opioid crisis for surgeons is the diversion of excess postoperatively prescribed opioids. Surgeons commonly prescribe excess opioid after surgery: a recent study revealed that 92% of a postoperative general surgery cohort had extra pills, 75% of which did not dispose of the excess. 12 In cohorts of C-section and thoracic surgery patients, these leftover pills are stored in unlocked cabinets within the home approximately 75% of the time. 30 Hence, it seems reasonable that the majority of prescription opioid abusers obtain them from family members with excess pills. 31 These findings are alarming and point to the urgent need for changes to postoperative prescribing habits-immediately after surgery and at postoperative office visits. Interventions to curb excessive prescription have been proposed. Electronic prescriptions for opioids may be one way to prevent surgeons from feeling that they need to overprescribe ''just in case,'' especially for patients traveling from long distances. 32 A large prospective study in orthopedic surgery revealed routine prescription of nearly 3 times the amount of opioid necessary, leading to strong recommendations for customized opioid prescriptions on the basis of anatomic location and procedure type. 33 Scully et al developed a model to obtain ideal initial prescription duration while still achieving adequate pain management by looking at median observed prescription lengths and nadirs in refill rates. 34 Further interventions and monitoring of their success are needed to stem the tide of this crisis. Although the current study examined ambulatory opioid prescription and did not address postoperative prescription due to the limitations of the database used, as surgeons we must be aware of the downstream effects of our prescribing habits.
The most striking finding in the present study remains that the ambulatory opioid prescription rate in otolaryngology doubled between 2008 and 2011 ( Figure 1) . Interestingly, this trend reflects national overdose mortality rates, which also increased during the same period. 35 This is not to overstate the data, however; \4% of office otolaryngology visits result in an opioid prescription. While a sobering reminder that our field is not immune to this crisis, the findings of our study do offer opportunity to target certain ''high risk'' diagnoses more effectively and increase provider caution. Some limitations of the current study include coding errors within a large public database and possible bias in sampling of office visits. These represent inherent challenges in large retrospective database studies and are difficult to correct. However, these disadvantages are likely offset by the relatively large sample size and the nationally representative data obtained.
In the current public health climate, otolaryngologists need to be more judicious and acutely aware of their opioid prescription habits than ever before. Concerted efforts are underway from federal-and state-level legislature to curb mortality rates from opioid misuse, and as surgeons we have a responsibility to be informed and align ourselves with the mission. Fortunately, despite the opioid epidemic in the United States, this study revealed that only a small portion of otolaryngology visits (3.8% 6 0.4%) were associated with opioid prescription. However, given the significant increase in prescribing from 2008 to 2011, continued surveillance of prescribing patterns is warranted. Further work is also required to determine appropriate pediatric posttonsillectomy and/or adenoidectomy analgesia regimens given the high proportion of codeine prescriptions provided in the recent past.
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